About BioVendor
BioVendor is a company based in Asheville (United States) founded in 1992. It operates as a B2B2C, Reseller / Distribution, and HealthTech. BioVendor has completed 3 acquisitions, including DIAsource ImmunoAssays, Immunolab and Oxford Biosystems. BioVendor offers products and services including Immunoassays, Antibodies & Recombinant Proteins, Next Generation Sequencing Kits, and Endotoxin Detection & Removal.
- Headquarter Asheville, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website biovendor.com
- Social LinkedIn YouTube
- Legal Name Biovendor – Laboratorni Medicina A.S.
- Latest Funding Round$251K (USD), Grant
Jan 2023
- InvestorsEuropean Union
& 1 more
- Investments & AcquisitionsDIAsource ImmunoAssays
& 2 more
Products & Services of BioVendor
BioVendor offers a comprehensive portfolio of products and services, including Immunoassays, Antibodies & Recombinant Proteins, Next Generation Sequencing Kits, and Endotoxin Detection & Removal.
Validated kits are provided for reliable diagnostic results.
High purity reagents are offered for research accuracy.
Advanced kits are developed for genetic cancer profiling.
Solutions are provided for safe biological sample processing.
Apps and channels of BioVendor
its YouTube channel BioVendor Group has 514 subscribers and 30 videos.
Videos from BioVendor
The most watched videos on BioVendor's YouTube channel, BioVendor Group (514 subscribers). Click a video to play it here.
More on BioVendor Group.
Funding Insights of BioVendor
- Total Rounds 4
- Last Round Grant — $250,999
- First Round $25,121
(Jun 2015)
- Investors Count 2
All 4 funding rounds of BioVendor with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2023 | $250,999 | Grant | – | – | |
| May 2021 | $91,155 | Grant | – | – | |
| Feb 2019 | $126,474 | Grant | – | – | |
| Jun 2015 | $25,121 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in BioVendor
BioVendor has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Portál veřejné správy.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
A digital platform for public administration services in Czech Republic. | – | gov.cz | Czech Republic |
Investor details for BioVendor
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioVendor
BioVendor has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include DIAsource ImmunoAssays, Immunolab and Oxford Biosystems.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
DIAsource Vitamin D expert in RIA, ELISA & Antibodies | diasource-diagnostics.com | – | 1996 | Jul 2017 | $18.11M | |
Diagnostic kits and reagents are manufactured for therapeutic areas. | oxfordbiosystems.com | Abingdon, United Kingdom | 2001 | Jun 2015 | •••• | |
Immunoassay diagnostic kits | immunolab.de | Kassel, Germany | 1992 | Feb 2014 | •••• |
Complete acquisition details for BioVendor
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of BioVendor
6 dated milestones of BioVendor across 31 years, from founding to its latest funding, stage changes and deals.
- Founded BioVendor is founded.
- Acquisition Acquires Immunolab.
- Funding First funding round of $25K.
- Acquisition Acquires Oxford Biosystems.
- Acquisition Acquires DIAsource ImmunoAssays.
- Funding Latest funding round, Grant, of $251K.
Web traffic of BioVendor
The website of BioVendor (biovendor.com) receives about 21.2K visits a month.
- Monthly visits21.2K
▲ 5.7% vs previous month
Websites whose visitors overlap most with BioVendor. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
ebiohippo.com | ebiohippo.com | 100% | – | #1,393,194 | – |
| fn-test.com | 99% | – | #994,608 | View details | |
| arborassays.com | 97% | 12K | #2,014,158 | View details | |
| rapidmicrobiology.com | 89% | 49.3K | #688,402 | View details | |
| salimetrics.com | 87% | – | #1,800,728 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for BioVendor
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Biovendor
Complete news archive for BioVendor
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to BioVendor
10 companies that operate in the same segment as BioVendor (Diagnostics & Lab Tech), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceuticals and diagnostics kits are developed for various diseases. | 1896 | Basel, Basel-stadt, Switzerland | – | USD 77.61 B | 103,250 | |
Point-of-care and laboratory blood analyzers are developed by EKF. | 1990 | Penarth, Wales, United Kingdom | USD 178.63 K | USD 69.43 M | 303 | |
Blood testing services are offered using finger-prick microsamples. | 2017 | Austin, Texas, United States | USD 37.7 M | – | – | |
Manufactures clinical diagnostic test kits | 1971 | Irvine, California, United States | – | USD 4.45 M | 54 | |
Biomarker-based diagnostic solutions for cancer and cardiovascular diseases are developed. | 2002 | Hennigsdorf, Brandenburg, Germany | USD 36.14 M | – | – | |
Diagnostic instrumentation and assays | 1987 | Puteaux, Hauts-de-seine, France | – | – | – | |
Manufacturer of Laboratory equipment | 1955 | Norwood, Massachusetts, United States | – | – | – | |
Cloud based diagnostics platform for point of care diagnosing | 2014 | Waltham, Massachusetts, United States | USD 703.91 M | USD 115.02 K | 9 | |
Diagnostics technology for infectious diseases and health monitoring is provided. | 2012 | Hong Kong, China | USD 34 M | – | – | |
Global leader for In Vitro Diagnostic | 1959 | Barcelona, Catalonia, Spain | – | USD 61.01 M | 346 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about BioVendor
BioVendor was founded in 1992 and raised its 1st funding round 23 years after it was founded.
BioVendor is headquartered in Asheville, United States. It is registered at Asheville, North Carolina, United States.
BioVendor is involved in the development, production, and distribution of in-vitro diagnostic (IVD) products and technologies for laboratory automation. The company focuses on immunoassays, recombinant proteins, antibodies, and endotoxin detection and removal products. Solutions are provided for various research and diagnostic needs, including next-generation sequencing, molecular diagnostics, and point-of-care testing. Operations span across biotechnology and healthcare sectors, with an emphasis on innovative diagnostics for conditions like chronic kidney disease and atopic dermatitis. Products are distributed globally through a network of partners and distributors.
BioVendor offers Immunoassays, Antibodies & Recombinant Proteins, Next Generation Sequencing Kits, and Endotoxin Detection & Removal.
BioVendor has made 3 acquisitions, including DIAsource ImmunoAssays, Immunolab, and Oxford Biosystems.
BioVendor has 2 investors. Key investors include European Union, and Portál veřejné správy.
BioVendor operates through Biovendor – Laboratorni Medicina A.S..